Literature DB >> 14803640

Therapy of infection with pneumonia virus of mice (PVM); effect of a polysaccharide on the multiplication cycles of the virus and on the course of the viral pneumonia.

H S GINSBERG, F L HORSFALL.   

Abstract

Inhibition of the multiplication of PVM by the capsular polysaccharide of Friedländer bacillus, type B, is associated with restriction in the development of pneumonia induced with the virus in the mouse lung. The extent of the pneumonic process appears to be a function of the degree of viral multiplication; the greater the inhibition of multiplication, the less extensive is the pneumonia and the more probable is the recovery of animals treated with the polysaccharide. Effective therapy of pneumonia induced in mice with PVM is obtained with a single injection of 0.02 mg. of the substance given intranasally either 2 or 3 days after inoculation. Under appropriate conditions, treated animals recover completely from a viral infection which is, in control animals, uniformly fatal. The polysaccharide produces inhibition if given in the first two-thirds of the latent period of the multiplication cycle, i.e., within 10 hours, but is ineffective when given at 12 hours or later. However, the second cycle and subsequent cycles are inhibited irrespective of the time the substance is injected during the first cycle of multiplication. The findings are discussed in relation to a theory regarding the mechanism of action of the polysaccharide.

Entities:  

Keywords:  PNEUMONIA, VIRAL; POLYSACCHARIDES; VIRUSES

Mesh:

Substances:

Year:  1951        PMID: 14803640      PMCID: PMC2136056          DOI: 10.1084/jem.93.2.161

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Modification of the Course of a Viral Pneumonia in Mice.

Authors:  H S Ginsberg
Journal:  Bull N Y Acad Med       Date:  1950-08

2.  Characteristics of the multiplication cycle of pneumonia virus of mice (PVM).

Authors:  H S GINSBERG; F L HORSFALL
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

3.  The dependence of the pathological lesion upon the multiplication of pneumonia virus of mice (PVM); kinetic relation between the degree of viral multiplication and the extent of pneumonia.

Authors:  F L HORSFALL; H S GINSBERG
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

4.  THE MODIFYING EFFECTS OF CERTAIN SUBSTANCES OF BACTERIAL ORIGIN ON THE COURSE OF INFECTION WITH PNEUMONIA VIRUS OF MICE (PVM).

Authors:  F L Horsfall; M McCarty
Journal:  J Exp Med       Date:  1947-05-31       Impact factor: 14.307

5.  The inhibitory effect of polysaccharide on mumps virus multiplication.

Authors:  H S GINSBERG; W F GOEBEL; F L HORSFALL
Journal:  J Exp Med       Date:  1948-05-01       Impact factor: 14.307

6.  STUDIES ON PNEUMONIA VIRUS OF MICE (PVM) : III. HEMAGGLUTINATION BY THE VIRUS; THE OCCURRENCE OF COMBINATION BETWEEN THE VIRUS AND A TISSUE SUBSTANCE.

Authors:  E C Curnen; F L Horsfall
Journal:  J Exp Med       Date:  1946-01-31       Impact factor: 14.307

7.  The effect of polysaccharides on the reaction between erythrocytes and viruses, with particular reference to mumps virus.

Authors:  H S GINSBERG; W F GOEBEL; F L HORSFALL
Journal:  J Exp Med       Date:  1948-05-01       Impact factor: 14.307

8.  PROPERTIES OF PNEUMONIA VIRUS OF MICE (PVM) IN RELATION TO ITS STATE.

Authors:  E C Curnen; F L Horsfall
Journal:  J Exp Med       Date:  1947-01-01       Impact factor: 14.307

9.  CHEMICAL STUDIES ON HOST-VIRUS INTERACTIONS : II. THE CHEMICAL SIMULATION OF THE INTERFERENCE PHENOMENON BY 5-METHYL TRYPTOPHANE.

Authors:  S S Cohen; T F Anderson
Journal:  J Exp Med       Date:  1946-10-31       Impact factor: 14.307

10.  A resistant variant of mumps virus; multiplication of the variant in the presence of inhibitory quantities of Friedländer bacillus polysaccharide.

Authors:  H S GINSBERG; F L HORSFALL
Journal:  J Exp Med       Date:  1949-11       Impact factor: 14.307

  10 in total
  17 in total

1.  Virus reproduction and virus disease.

Authors:  F L HORSFALL
Journal:  Can Med Assoc J       Date:  1955-11-15       Impact factor: 8.262

2.  [The dependance of antiviral effect of bacterial polysaccharides on treatment time, treatment dosis and the degree of infection].

Authors:  F KRADOLFER; R WYLER; R MEIER
Journal:  Experientia       Date:  1957-05-15

3.  Approaches to the chemotherapy of viral diseases.

Authors:  F L HORSFALL
Journal:  Bull N Y Acad Med       Date:  1955-11

4.  Interferon production in mice by the capsular polysaccharide of Klebsiella pneumoniae.

Authors:  N Kato; I Nakashima; M Ota
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

5.  Mechanisms of man's resistance to infectious diseases.

Authors:  W J NUNGESTER
Journal:  Bacteriol Rev       Date:  1951-09

6.  Characteristics of the multiplication cycle of pneumonia virus of mice (PVM).

Authors:  H S GINSBERG; F L HORSFALL
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

Review 7.  Pneumonia virus of mice: severe respiratory infection in a natural host.

Authors:  Helene F Rosenberg; Joseph B Domachowske
Journal:  Immunol Lett       Date:  2008-04-22       Impact factor: 3.685

8.  Antiviral chemotherapy.

Authors:  I TAMM
Journal:  Yale J Biol Med       Date:  1956-09

Review 9.  The Pneumonia Virus of Mice (PVM) model of acute respiratory infection.

Authors:  Kimberly D Dyer; Katia E Garcia-Crespo; Stephanie Glineur; Joseph B Domachowske; Helene F Rosenberg
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

10.  Effect of sodium monofluoroacetate on the multiplication of influenza viruses, mumps virus and pneumonia virus of mice (PVM).

Authors:  W J MOGABGAB; F L HORSFALL
Journal:  J Exp Med       Date:  1952-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.